Roche Molecular Systems, Inc. · Class II · Cleared Dec 5, 2019
| K-number | DEN190016 |
| Device name | cobas vivoDx MRSA |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | QIV |
| Device class | Class II |
| Decision date | Dec 5, 2019 |
| Decision | Not Substantially Equivalent |
| Regulation | — |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov